Jérôme Moreaux
Institut Universitaire de France(FR)Université de Montpellier(FR)Centre Hospitalier Universitaire de Montpellier(FR)Institut de Génétique Humaine(FR)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways
Most-Cited Works
- → BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone(2003)563 cited
- → Embryonic stem cell markers expression in cancers(2009)262 cited
- → The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature(2005)257 cited
- → CD200 is a new prognostic factor in multiple myeloma(2006)230 cited
- → Survival and Proliferation Factors of Normal and Malignant Plasma Cells(2003)211 cited
- → Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma(2010)201 cited